Kayoko Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kayoko Tanaka has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Hiroaki Iwata
Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan
3 shared publications - Maho Matsuo
Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan
2 shared publications - Naohisa Ichiki
Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan
2 shared publications Ryota Asahina
Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan
2 shared publicationsChisato Tawada
Department of Dermatology Gifu University Graduate School of Medicine Gifu Japan
1 shared publication- Chisato Tawada
Department of Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan
1 shared publication
Latest Publications
- 5 December 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
A Case of Generalized Fixed Drug Eruption Showing the Conjunctival Involvement With CD4 + Tissue‐Resident Memory T Cell Accumulation
- 5 December 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
A Case of Generalized Fixed Drug Eruption Showing the Conjunctival Involvement With CD4 + Tissue‐Resident Memory T Cell Accumulation
- 8 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1452-1455
A Case of Local Relapse of Pemphigus Vegetans Detected IL ‐ 17A + Tissue‐Resident Memory T Cells in Lesional Skin
A 49‐year‐old man with pemphigus vegetans (PVeg) relapsed several times due to cessation of therapy. At the age of 66, vegetative plaques developed at the left oral commissure following mechanical plucking of approximately 500 beard hairs. Treatment with prednisolone (20 mg/day) was continued but yielded no clinical improvement. Subsequently, rituximab (1000 mg twice, 2 weeks apart) led to a rapid decline of anti‐desmoglein 3 (Dsg3) autoantibody and clinical improvement. The lesion resolved after 18 months, and prednisolone was tapered without recurrence. Based on the site‐specific recurrence and chronicity, we hypothesized that tissue‐resident memory T (T RM ) cells and high endothelial venules (HEV)‐like vessels contributed to disease persistence. Immunohistochemical analysis revealed a substantial presence of IL‐17A‐producing CD69 + + CD103 + + T RM cells in the dermis. In addition, PNAd+ + HEV‐like vessels were increased, accompanied by infiltrates of B cells and plasma cells. Notably, Dsg3‐specific B cells were also detected, indicating that rituximab‐mediated B cell depletion likely contributed to lesion resolution in this case.
- 8 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (9) , 1452-1455
A Case of Local Relapse of Pemphigus Vegetans Detected IL ‐ 17A + Tissue‐Resident Memory T Cells in Lesional Skin
A 49‐year‐old man with pemphigus vegetans (PVeg) relapsed several times due to cessation of therapy. At the age of 66, vegetative plaques developed at the left oral commissure following mechanical plucking of approximately 500 beard hairs. Treatment with prednisolone (20 mg/day) was continued but yielded no clinical improvement. Subsequently, rituximab (1000 mg twice, 2 weeks apart) led to a rapid decline of anti‐desmoglein 3 (Dsg3) autoantibody and clinical improvement. The lesion resolved after 18 months, and prednisolone was tapered without recurrence. Based on the site‐specific recurrence and chronicity, we hypothesized that tissue‐resident memory T (T RM ) cells and high endothelial venules (HEV)‐like vessels contributed to disease persistence. Immunohistochemical analysis revealed a substantial presence of IL‐17A‐producing CD69 + + CD103 + + T RM cells in the dermis. In addition, PNAd+ + HEV‐like vessels were increased, accompanied by infiltrates of B cells and plasma cells. Notably, Dsg3‐specific B cells were also detected, indicating that rituximab‐mediated B cell depletion likely contributed to lesion resolution in this case.
- Open Access
- 16 April 2024
- Published by Elsevier in JID Innovations
- Vol. 4 (4) , 100282
Diacron-Reactive Oxygen Metabolites Levels Are Initially Elevated in Patients with Bullous Pemphigoid
- 16 April 2024
- Published by Elsevier in JID Innovations
- Vol. 4 (4) , 100282
Open AccessDiacron-Reactive Oxygen Metabolites Levels Are Initially Elevated in Patients with Bullous Pemphigoid